Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:1242-1243 (26 November), doi:10.1136/bmj.38573.696100.3A (published 21 September 2005)
R J Pitman, senior scientist1, B S Cooper, senior scientist1, C L Trotter, senior scientist1, N J Gay, principal scientist1, W J Edmunds, principal scientist1
1 Modelling and Economics Unit, Health Protection Agency, Centre for Infections, London NW9 5EQ
Correspondence to: R J Pitman richard.pitman{at}hpa.org.uk
We assess the possible benefit of entry screening for SARS and pandemic influenza should an epidemic occur.
We estimated the incubation periods for influenza and SARS from published sources.1 2 We used these distributions to estimate the proportion of individuals with initially latent SARS and influenza infection developing symptoms during a flight from any of the top 100 sources of international airline passengers to the United Kingdom, given information on the mean duration of a direct flight from these destinations (www.britishairways.com/travel/schedules/public/en_gb). For influenza, given an overall prevalence of individuals with latent infection, we used existing transmission models2 to estimate the proportion expected to have been infected one, two, or more days previously, during the increasing phase of the epidemic. We back calculated corresponding proportions for SARS from the incidence of infection in Hong Kong at the start of the epidemic.
For SARS, the probability of in-flight progression rises slowly with the duration of the flight. During a six hour transatlantic flight, an infected passenger would have a 0-11% chance of progression, depending on the time since infection. Between 1% and 21% of such infected individuals arriving from East Asian cities (10 hour flight) would be expected to be detected.
Influenza has a much shorter incubation period than SARS, so the probability of progression during the flight is higher. A passenger infected two days before departure would have a 50% chance of progression during a 10 hour flight. As most flights are of much shorter duration, the mean predicted proportion of people infected with influenza and progressing during the flight was less than 10%. The proportion of infected individuals detected is highest from cities with the longest flight duration (table). Screening passengers from the Far East and Australasia therefore derives the most benefit. Even then, the sensitivity for cities in these areas would still be low.
|
|
We have ignored the possibility of in-flight transmission. Such transmission has been documented for SARS as well as influenza.3-5 However, because time would be insufficient for new secondary cases to develop symptoms and become detectable by screening, this omission will tend to overestimate rather than underestimate the proportion of infected individuals detected by entry screening. Adopting a policy of quarantining all exposed passengers on the detection of a single case could, however, substantially increase the benefit of entry screening. However, this still leaves the principal problem that the sensitivity of entry screening is low.
This article was posted on bmj.com on 23 September 2005: http://bmj.com/cgi/doi/10.1136/bmj.38573.696100.3A
Contributors: See bmj.com
Funding: UK Department of Health.
Competing interests: None declared.
Ethical approval: Not required.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?